Document:

Exhibit 10.8

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement
(this “Agreement”) is entered into as of [____] (the “Effective Date”) by and between Nava Health
MD, LLC (the “Company” or “Nava”) and [__________] (the “Executive”).

 

WITNESSETH:

 

WHEREAS, the Company desires
the employment of the Executive in accordance with the provisions of this Agreement; and

 

WHEREAS, the Executive desires
and is willing to be employed by the Company in accordance with the provisions of this Agreement.

 

NOW THEREFORE, in consideration
of the premises and mutual covenants contained herein, and intending to be legally bound, the parties agree as follows:

 

1.                 
Employment.

 

(a)              
Position. On the terms and subject to the conditions set forth in this Agreement, the Company shall employ the Executive
and the Executive shall serve the Company as [_______________________].

 

(b)              
Duties. The Executive’s duties shall be prescribed from time to time by the [_______________] of the Company and shall
include such responsibilities as are customary for employees performing functions similar to those of the Executive. The Executive shall
devote substantially all of the Executive’s time and attention to the performance of the Executive’s duties and responsibilities
for and on behalf of the Company except as set forth herein or as may be consented to by the Company.

 

(c)              
Outside Activities. Notwithstanding anything to the contrary herein, Executive shall be permitted: (i) to serve as a member
of the board of directors or advisory board (or their equivalents in the case of a non-corporate entity) of any charitable or philanthropic
organization; (ii) to engage in charitable, community or philanthropic activities or any other activities; or (iii) to serve as an executor,
trustee or in a similar fiduciary capacity; provided, that the activities set out in the foregoing clauses shall be limited by
the Executive so as not to affect, interfere or conflict with, individually or in the aggregate, the performance of the Executive's duties
and responsibilities. Any outside activities in excess of the foregoing shall require the consent of the [________________], whose consent
will not be unreasonably withheld, delayed or conditioned.

 

(d)              
Company Policies. The employment relationship between the parties shall also be subject to the Company’s personnel
policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion.
Notwithstanding the foregoing, in the event that the terms of this Agreement are in conflict with the Company’s general employment
policies or practices, this Agreement shall control.

 

    1

     

    

 

2.                 
 Term. This agreement shall remain in effect for two (2) years following the Effective Date unless sooner terminated in
accordance with Section 4. The period of time during which this Agreement remains in effect shall be referred to as the “Term.”
The parties expressly agree that designation of a Term does not in any way limit the right of the parties to terminate the Executive’s
employment at any time as hereinafter provided.

 

3.                 
Compensation. The Executive shall receive, for all services rendered to the Company pursuant to this Agreement, the following:

 

(a)       
Base Salary. The Employee shall be paid a base salary at the rate of [___________________________] per annum (the “Base
Salary”), less deductions for withholding taxes required under applicable law or as otherwise authorized by the Executive. The
Base Salary shall accrue from and after the Effective Date and shall be payable during the Term in equal periodic installments in accordance
with Company’s then current, general salary payment policies. The Executive’s Base Salary shall be reviewed periodically by
the [______________] and may be increased based upon the evaluation of the Executive’s performance and the compensation policies
of the Company in effect at the time of each such review.

 

(b)       Annual
Bonus. If Executive is employed by Nava through the last day of a calendar year during the Term, he/she may be entitled to receive
from Nava an amount up to [__]% of his/her Base Salary (“Annual Bonus”). The amount of the Annual Bonus, if any, shall be
determined by the Manager and be based on his/her annual performance review, Nava’s financial condition, and other annual performance
criteria established by the Manager in consultation with the Executive.

 

(c)       Equity
Compensation Plan. The Executive will be eligible to participate in any equity compensation plan established by Nava, subject to the
terms thereof, and to the extent that any discretionary awards are made thereunder by the Manager.

 

(d)       Benefits.

 

During the Term, the Company
shall provide the Executive with the following benefits:

 

(i)                
Group Health Plan. The Executive and his/her spouse shall be covered, if and to the extent eligible thereunder, by the group
health plan maintained by the Company (the “Group Health Plan”). During the Term, but only if the Group Health Plan
is fully insured, Nava shall pay the full cost of premiums for such coverage for the Executive and his/her spouse;

 

(ii)       Life
Insurance. Executive will be entitled to life insurance coverage in an amount equal to two (2) times his/her Base Salary under Nava’s
group term life insurance policy;

 

(iii)       LTD
Insurance. Nava will reimburse the Executive for the cost of purchasing long-term disability insurance under the terms of any policy
in effect as of the date hereof or another policy mutually agreeable to the Executive and Nava;

 

(e)       Condition
of Coverage. Nothing contained in this Agreement shall require Nava to establish, maintain, or continue any group health or life
insurance plan or restrict the right of Nava to amend, modify or terminate any such plan in a manner that does not discriminate
against the Executive as compared to other employees of Nava. If Nava cannot obtain the life and/or long-term disability insurance
coverage contemplated under Section 3(d) at standard rates under the terms of such insurance policies, then Nava will pay the
Executive the standard monthly premium in lieu of providing such coverage.

 

    2

     

    

 

(f)       Paid
Time Off. During the Term, the Executive shall be entitled to paid vacation, paid holidays and other paid time off (“PTO”)
for which executives of the Company are generally eligible, in each case consistent with Company policy in effect from time to time, but
not less than 25 days of PTO per calendar year during the Term. The Executive shall not be entitled to payment for unused PTO upon termination
of employment.

 

(g)       Withholding.
The Company is authorized to deduct and withhold from the Executive’s compensation all sums authorized by the Executive or necessary
or required (whether by law, court decree, executive order or otherwise), including, but not limited to, social security, income tax withholding
and otherwise, and any other amounts required by law or any taxing authority.

 

(h)       Expenses.
The Company shall reimburse the Executive for all reasonable out-of-pocket expenses incurred by the Executive in connection with the performance
of the Executive's duties and responsibilities hereunder upon presentment of a valid receipt or other usual and customary documents evidencing
such expenses. The Company will reimburse properly substantiated and timely submitted expenses no later than 30 days after the date that
the appropriate documentation is submitted by the Executive.

 

4.                 
Termination.

 

(a)              
Termination by the Executive For Any Reason, or by the Company With Cause. The employment of the Executive hereunder (and this
Agreement) may be terminated at any time by the Executive for any reason, or by the Company with Cause, in which event the Executive will
be entitled to the Standard Termination Benefits (as defined in Section 4(d)).

 

(b)       Termination
Due to Death or Disability of the Executive. The employment of the Executive hereunder (and this Agreement) shall terminate upon the
death or Disability of the Executive in which case Executive (or his/her estate, if applicable) will be entitled to the Standard Termination
Benefits (as defined in Section 4(d)). Executive (or his/her estate, if applicable) will also be entitled to the Severance Benefits
(as defined in Section 4(e)) in the event of termination due to death or Disability, subject to execution by the Executive of a
Release as described in Section 4(c) in the event of termination due to Disability. For purposes of this Agreement, “Disability”
shall mean a determination by the Manager that, because of a medically determinable disease, condition, injury or other physical or mental
disability, the Executive is unable to substantially perform his or her duties required hereby, and that such disability is determined
or reasonably expected to last for a continuous period of one hundred eighty (180) days (this definition to be interpreted and applied
consistently with the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable law).

 

(c)       Termination
by the Company without Cause. The employment of the Executive hereunder (and this Agreement) may be terminated at any time, at
the option of the Company without Cause. Termination by the Company without Cause shall be effective immediately after the Company
gives notice to Executive of Executive’s termination, unless the Company specifies a later date, in which case, termination
shall be effective as of such later date. If the Company terminates the Executive’s employment with the Company without Cause
as specified in the previous sentence, the Company shall pay to the Executive the Standard Termination Benefits. Additionally, if:
(i) the Executive delivers to the Company an effective, general release of claims in favor of the Company in a form substantially
similar to Exhibit A (the “Release”) within forty-five (45) days following the termination date; and (ii)
the Executive returns all Company property, complies in all material respects with his or her post-termination obligations under
this Agreement and the Release, and complies in all material respects with the Release including, without limitation, any
non-disparagement and confidentiality provisions contained therein, then the Executive shall receive the Severance Benefits.

 

    3

     

    

 

For purposes of this Agreement,
 “Cause” means: (i) an act of personal dishonesty in connection with the Executive’s responsibilities as an employee
of the Company that is intended to result in personal enrichment of the Executive; (ii) a plea of guilty or nolo contendere to, conviction
of, or an indictment for a felony or other crime involving theft, fraud, or moral turpitude in each case that the Manager reasonably believes
has had or will have a material detrimental effect on the Company’s reputation or business; (iii) a breach by the Executive of any
fiduciary duty owed to the Company that has, or is reasonably expected to have, a material detrimental effect on the Company’s reputation
or business as determined in good faith by the Manager; (iv) serious neglect or misconduct in the performance of Executive’s duties
for the Company; (v) willful or repeated failure or refusal to perform such duties if such failure continues uncured for ten (10) days
after written notice from the Manager(s) specifying in reasonable detail such failure; (vi) the material breach by the Executive of any
provision of Section 6 (Restrictive Covenants) hereof if (in the event such failure is reasonably susceptible of cure) such failure
continues uncured for ten (10) days after written notice from the Manager specifying in reasonable detail such failure; or (vii) the abuse
by the Executive of drugs or alcohol, if such abuse has or is reasonably expected to have a material adverse effect on the business of
the Company.

 

(d)       Standard
Termination Benefits in the Event of Separation from Employment. In the event that the Executive separates from employment for any
reason or no reason, the Company shall pay to the Executive within thirty (30) days of such termination: (i) accrued and unpaid Base Salary
in accordance with Section 3(a); (ii) any unreimbursed expenses payable in accordance with Section 3(e); and (iii) any amounts
payable under any of the benefit plans of the Company in which the Executive was a participant in accordance with applicable law and the
terms of those plans (collectively, the “Standard Termination Benefits”).

 

(e)       Severance.
Subject to Section 4(c), if the Company terminates the Executive’s employment at any time without Cause, or if the
Executive’s employment ends due to death or Disability, the Executive shall receive an amount equal to the Executive’s
then current Base Salary for twelve (12) months (the “Severance Period”), less all applicable withholdings and
deductions, paid in accordance with the Company’s standard payroll practices (subject to the provisions of this Section
4(e)), (the “Severance Benefits”). No payments of Severance Benefits will be made prior to the sixtieth
(60th) day following the Executive’s Separation from Service (as defined in Section 7(a)). On the 60th day following
the Executive’s Separation from Service (or within three business days thereafter), the Company will pay the Executive in a
lump sum the payments that the Executive would have received on or prior to such 60th day under the original schedule but
for the delay and with the balance of the payments being paid as originally scheduled. Moreover, if applicable, payments under this Section
4(e) shall be further delayed as described in Section 6(b).

 

    4

     

    

 

5.                 
Assignment of Intellectual Property Rights; Restrictive Covenants. In consideration of the Executive’s employment,
the Executive agrees to be bound by this Section 5.(a)General. The Executive agrees to assign, and hereby assigns, to the Company all
of his or her rights, title, and interest throughout the world in and to any Invention (as hereinafter defined) (including all Intellectual
Property Rights (as hereinafter defined) therein or related thereto) that were previously or are made, conceived or reduced to practice,
in whole or in part and whether alone or with others, by him or her during his or her employment by, or service with, the Company or
that arise out of any activity conducted by, for, or under the direction of the Company (whether or not conducted at the Company's facilities,
working hours, or using any of the Company’s assets) or that are useful with, or relate directly or indirectly to, any Company
Interest (as defined below). The Executive will promptly and fully disclose and provide all of the Inventions described above (the “Assigned
Inventions”) to the Company.

 

(b)             
Assurances. The Executive hereby agrees, during the Term and thereafter, to further assist the Company, at the Company’s
expense, to evidence, record and perfect the Company’s rights in and ownership of the Assigned Inventions, to perfect, obtain, maintain,
enforce and defend any rights specified to be so owned or assigned and to provide and execute all documentation necessary to effect the
foregoing, including the disclosure to the Company or its designee of all pertinent information and data with respect thereto, the execution
of all applications, specifications, oaths, assignments, recordations, and all other instruments that the Company or its designee shall
deem necessary in order to apply for, obtain, maintain and transfer such rights, or if not transferable, waive and agree never to assert
such rights, and in order to assign and convey to the Company or its designee, and any successors, assigns and nominees the sole and exclusive
right, title and interest in and to such Assigned Inventions, and any copyrights, patents, mask work rights or other intellectual property
rights relating thereto. Executive further agrees that his or her obligation to execute or cause to be executed any such instrument or
papers shall continue during and at all times after the end of the Term and until the expiration of the last such intellectual property
right to expire in any country of the world. Executive hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as his or her agent and attorney-in-fact to act for and in his or her behalf and stead to execute and file any such
instruments and papers and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance
or transfer of letters patent, copyright, mask work and other registrations related to such Assigned Inventions. This power of attorney
is coupled with an interest and shall not be affected by Executive’s subsequent incapacity.

 

(c)              
Other Inventions. The Executive agrees to not incorporate, or permit to be incorporated, any Invention conceived, created,
developed or reduced to practice by him or her (alone or with others) prior to or independently of his or her employment by the Company
or any of its subsidiaries (collectively, “Prior Inventions” disclosed on Exhibit B attached hereto) in any work he or she
performs for the Company without the Company’s prior written consent. If (i) he or she uses or discloses any Prior Inventions when
acting within the scope of his or her employment (or otherwise on behalf of the Company); or (ii) any Assigned Invention cannot be fully
made, used, reproduced or otherwise exploited without using or violating any Prior Inventions, the Executive hereby grants and agrees
to grant to the Company a perpetual, irrevocable, worldwide, royalty-free, non-exclusive, sublicensable right and license to reproduce,
make derivative works of, distribute, publicly perform, publicly display, make, have made, use, sell, import, offer for sale, and otherwise
exploit and exercise all such Prior Inventions and Intellectual Property Rights therein.

 

    5

     

    

 

(d)              
Definitions. “Company Interest” means any business of the Company or any product, service, Invention or Intellectual
Property Right that is used or under consideration or development by the Company. “Intellectual Property Rights” means any
and all intellectual property rights and other similar proprietary rights in any jurisdiction, whether registered or unregistered, and
whether owned or held for use under license with any third party, including all rights and interests pertaining to or deriving from: (a)
patents and patent applications, reexaminations, extensions and counterparts claiming property therefrom; inventions, invention disclosures,
discoveries and improvements, whether or not patentable; (b) computer software and firmware, including data files, source code, object
code and software-related specifications and documentation; (c) works of authorship, whether or not copyrightable; (d) trade secrets (including
those trade secrets defined in the Uniform Trade Secrets Act and under corresponding statutory law and common law), business, technical
and know-how information, non-public information, and confidential information and rights to limit the use of disclosure thereof by any
person; (e) trademarks, trade names, service marks, certification marks, service names, brands, trade dress and logos and the goodwill
associated therewith; (f) proprietary databases and data compilations and all documentation relating to the foregoing, including manuals,
memoranda, and record; (g) domain names; and (h) licenses of any of the foregoing, including in each case any registrations of, applications
to register, and renewals and extensions of, any of the foregoing with or by any governmental authority in any jurisdiction. “Invention”
means any products, processes, ideas, improvements, discoveries, developments, methods, techniques, know how, inventions, designs, algorithms,
financial models, formulas, writings, works of authorship, content, graphics, data, software, specifications, instructions, text, images,
photographs, illustration, audio clips, trade secrets and other works, material and information, tangible or intangible, whether or not
it may be patented, copyrighted or otherwise protected (including all versions, modifications, enhancements and derivative work thereof).

 

(e)       Restrictive
Covenants. The Executive agrees to be bound by the provisions of Exhibit C, which are incorporated herein by reference.

 

6.                 
Sections 409A of the Internal Revenue Code.

 

(a)       Separation
from Service. Notwithstanding anything in this Agreement to the contrary, to the extent that any severance or other payments or
benefits paid or provided to Executive, if any, under this Agreement are considered deferred compensation subject to Section
409A of the Code and the final regulations and any guidance promulgated thereunder (“Section 409A”) (such
payments, the “Deferred Payments”), then to the extent required by Section 409A, no Deferred Payments will be
payable unless Executive’s termination of employment also constitutes a “separation from service,” as defined in
Treasury Regulations Section 1.409A-1(h) (a “Separation from Service”). Similarly, no Deferred Payments payable
to Executive, if any, under this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulations Section
1.409A-1(b)(9) will be payable until Executive has a Separation from Service. For clarity, if Executive’s employment with
the Company is terminated by Executive or the Company (including, without limitation, by resignation) in a manner entitling
Executive to Severance Benefits, but the Executive does not incur a Separation from Service, then any severance payments or benefits
that are Deferred Payments and that are not immediately payable under this Section 7(a) will instead be paid to Executive
when Executive incurs a Separation from Service as if termination of employment occurred on such date notwithstanding that Executive
may no longer be employed under this Agreement.

 

    6

     

    

 

(b)       Payment
Delay. If, at the time of Executive’s Separation from Service, the Company determines that Executive is a “specified employee”
for purposes of Section 409A(a)(2)(B)(i) of the Code and that delayed commencement of any portion of the Deferred Payments is required
to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code (any such delayed commencement, a “Payment
Delay”), then that portion of the Deferred Payments will not be provided to Executive until the earlier of (i) the expiration of
the six-month period measured from the date of Executive’s Separation from Service; (ii) the date of Executive’s death; or
(iii) such earlier date as is permitted under Section 409A. Upon the expiration of the applicable Code Section 409A(a)(2)(B)(i)
deferral period, all Deferred Payments deferred under the Payment Delay will be paid in a lump sum to Executive within 30 days following
such expiration, and any remaining payments due under this Agreement will be paid as otherwise provided in this Agreement. The determination
of whether Executive is a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code at the time of
Executive’s Separation from Service will be made by the Company, in its discretion, in accordance with Section 409A (including,
without limitation, Treasury Regulations Section 1.409A-1(i)). For purposes of Section 409A (including, without limitation,
for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)), Executive’s right to receive the payments under this Agreement,
including the severance payments and benefits, will be treated as a right to receive a series of separate payments and, accordingly, each
installment payment will at all times be considered a separate and distinct payment.

 

(c)       Expense
Reimbursement. If required for compliance with Section 409A of the Code, any expenses incurred by Executive that are reimbursed
by the Company as a taxable reimbursement under this Agreement will be paid in accordance with Treasury Regulations Section 1.409A-3(i)(1)(iv)
and in accordance with the Company’s standard expense reimbursement policies, but in any event on or before the last day of Executive’s
taxable year following the taxable year in which Executive incurred the expenses. The amounts so reimbursed during any taxable year of
Executive will not affect the amounts provided in any other taxable year of Executive, and Executive’s right to reimbursement for
these amounts will not be subject to liquidation or exchange for any other benefit.

 

7.                 
Attorneys’ Fees. If any action at law or in equity (including arbitration) is necessary to enforce or interpret the
terms of any provision of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary
disbursements in addition to any other relief to which such party may be entitled pursuant to the underlying action.

 

8.                 
No Conflicts. The Executive represents and warrants to the Company that the execution, delivery and performance by the
Executive of this Agreement do not conflict with or result in a violation or breach of, or constitute (with or without the giving of
notice or the lapse of time or both) a default under any contract, agreement or understanding, whether oral or written, to which the
Executive is a party or by which the Executive is bound and that there are no restrictions, covenants, agreements or limitations on the
Executive’s right or ability to enter into and perform the terms of this Agreement, and the Executive agrees to indemnify and save
the Company harm from any liability, cost, or expense, including attorney's fees, based upon or arising out of any breach of this Section
8.

 

    7

     

    

 

9.                 
Waiver. The waiver by either party of any breach by the other party of any provision of this Agreement shall not operate
or be construed as a waiver of any subsequent breach by such party. No person acting other than pursuant to a resolution of the Company
shall have authority on behalf of the Company to agree to amend, modify, repeal, waive or extend any provision of this Agreement.

 

10.             
Successors and Assigns; Assignment. This Agreement shall be binding upon and inure to the benefit of the successors and
assigns of the Company. Upon conversion of the Company to corporate form, references in this Agreement to “Manager(s)” shall
be deemed to refer to the Board of Directors of the Company, except that, upon such conversion, references to the “Manager”
in Sections 3(b) and 3(c) herein shall be deemed to refer specifically to the Compensation Committee of the Board of Directors. This Agreement
shall inure to the benefit of and be enforceable by the Executive or his or her legal representatives, executors, administrators and heirs.
The Executive may not assign any of the Executive’s duties, responsibilities, obligations or positions hereunder to any person,
and any such purported assignment by the Executive shall be void and of no force and effect.

 

11.             
Notices. All notices, requests, demands, and other communications that are required or may be given pursuant to this Agreement
shall be in writing and shall be deemed to have been duly given when received if personally delivered, upon confirmation of transmission
if sent by telecopy, electronic, or digital transmission, the day after it is sent, if sent for next day delivery to a domestic address
by a recognized overnight delivery service (e.g., Federal Express), and upon receipt, if sent by certified or registered mail, return
receipt requested. In each case, notice shall be sent to:

 

If to Executive, addressed
to:

 

[________________]

 

If to the Company, addressed
to:

 

Nava Health MD, LLC

9755 Patuxent Woods Drive

Columbia, Maryland 21046

[______________]

 

or to such other place and with such other copies
as either party may designate as to itself by written notice to the others.

 

    8

     

    

 

12.             
 Miscellaneous.

 

(a)       Governing
Law; Jurisdiction/Venue. This Agreement shall be governed by, and its provisions construed and enforced in accordance with, the internal
laws of the State of Maryland without reference to its principles regarding conflicts of law. Both parties agree to submit to the exclusive
jurisdiction and venue of the state and federal courts located in the State of Maryland for any disputes arising out of this Agreement.

 

(b)       Waiver
of Jury Trial. The parties hereby waive their respective rights to a trial by jury and further agree that no demand, request or motion
will be made for trial by jury.

 

(c)       Severability.
In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the validity,
legality or enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(d)       Headings.
The descriptive headings of the several paragraphs of this Agreement are inserted for convenience of reference only and shall not constitute
a part of this Agreement.

 

(e)       Entire
Agreement. This Agreement, inclusive of exhibits and schedules, contains the entire agreement of the parties concerning the Executive’s
employment and all promises, representations, understandings, arrangements and prior agreements on such subject are merged herein and
superseded hereby.

 

(f)       Representation
by Counsel. Each of the parties hereto acknowledges that: (i) it or he or she has read this Agreement in its entirety and understands
all of its terms and conditions; (ii) it or he or she has had the opportunity to consult with any individuals of its or his or her choice
regarding its or his or her agreement to the provisions contained herein, including legal counsel of its or his or her choice, and any
decision not to was its or his or her alone; and (iii) it or he or she is entering into this Agreement of its or his or her own free will,
without coercion from any source.

 

(g)       Survival.
The provisions of this Agreement that remain applicable following termination of employment shall survive termination of this Agreement.

 

(h)       Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall
constitute one and the same Agreement. Delivery of facsimile or .pdf, or other electronic copies (complying with the U.S. federal ESIGN
Act of 2000 (e.g., www.docusign.com)) of signature pages for this Agreement shall be valid and treated for all purposes as delivery of
the originals.

 

[SIGNATURES ON FOLLOWING PAGE]

 

    9

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Agreement to be executed by its duly authorized officer, and the Executive has set his or her hand, all effective as of the Effective
Date.

 

	 	NAVA
    HEALTH MD, LLC	 
	 	 	 
	 	By:	                                     	 
	 	 	 
	 	Name:	 	 
	 	 	 
	 	Title:	 	 
	 	 	 
	 	Date:	 	 
	 	 	 
	 	 	 
	 	EXECUTIVE	 
	 	 	 
	 	 	 
	 	[_________________]       	 
	 	 	 
	 	Date:	 	 

 

    10

     

    

 

EXHIBIT A

 

Release Agreement

 

This Release Agreement (“Release”)
is made by and between Nava Health MD, LLC (the “Company”) and [___________] (“you”). You and the Company entered
into an Executive Employment Agreement dated _______________ (the “Employment Agreement”). You and the Company hereby further
agree as follows:

 

1.       A
blank copy of this Release was attached to the Employment Agreement as Exhibit A.

 

2.       Severance
Payments. If your employment was terminated by the Company without Cause or due to your Disability (as defined in the Employment Agreement),
then in consideration for your execution, return, and non-revocation of this Release, following the Release Date (as defined in Section
3 below), the Company will provide the severance benefits set forth in your Employment Agreement.

 

3.       Release
by You. In exchange for the payments and other consideration under this Agreement, to which you would not otherwise be entitled, and except
as otherwise set forth in this Agreement, you hereby generally and completely release, acquit and forever discharge the Company, its respective
subsidiaries, affiliates, predecessors, current and former directors, members, officers, employees, agents, stockholders, heirs, beneficiaries,
its successors and assigns (both individually and in their official capacities), its parents and subsidiaries, and its officers, directors,
managers, partners, agents, servants, employees, attorneys, shareholders, successors, assigns and affiliates (the “Company Parties”)
of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and
obligations of every kind and nature, in law, equity, or otherwise, both known and unknown, suspected and unsuspected, disclosed and undisclosed,
arising out of or in any way related to agreements, events, acts or conduct at any time prior to and including the execution date of this
Agreement, including but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with
your employment with the Company or the termination of that employment; claims or demands related to salary, bonuses, commissions, stock,
stock options, or any other ownership interests in the Company; vacation pay, fringe benefits, expense reimbursements, severance pay,
or any other form of compensation; claims pursuant to any federal, state or local law, statute, or cause of action; tort law; or contract
law. The claims and causes of action you are releasing and waiving in this Agreement include, but are not limited to, any and all claims
and causes of action that the Company Parties:

 

• have violated their
personnel policies, handbooks, contracts of employment, or covenants of good faith and fair dealing;

 

• have
discriminated, harassed, or retaliated against you on the basis of age, race, color, sex (including sexual harassment), national
origin, ancestry, disability, religion, sexual orientation, marital status, parental status, source of income, entitlement to
benefits, any union activities or other protected category in violation of any local, state or federal law, constitution, ordinance,
or regulation, including but not limited to: the Age Discrimination in Employment Act, as amended (“ADEA”); Title VII of
the Civil Rights Act of 1964, as amended; 42 U.S.C. § 1981, as amended; the Civil Rights Act of 1866; the Worker Adjustment
Retraining and Notification Act; the Equal Pay Act; the Americans With Disabilities Act; the Genetic Information Non-Discrimination
Act; the Family Medical Leave Act; the Occupational Safety and Health Act; the Immigration Reform and Control Act; the Uniform
Services Employment and Reemployment Rights Act of 1994, as amended; Section 510 of the Employee Retirement Income Security
Act; and the National Labor Relations Act;

 

    11

     

    

 

• have violated any
statute, public policy or common law (including but not limited to claims for retaliatory discharge; negligent hiring, retention or supervision;
defamation; intentional or negligent infliction of emotional distress and/or mental anguish; intentional interference with contract; negligence;
detrimental reliance; loss of consortium to you or any member of your family; and/or promissory estoppel).

 

Notwithstanding the foregoing, you are not releasing
any right of indemnification that you may have for any liabilities arising from your actions within the course and scope of your employment
with the Company or within the course and scope of your role as a member of the Board of Directors and/or officer of the Company (if applicable).
Also excluded from this Agreement are any claims that cannot be waived by law. You are waiving, however, your right to any monetary recovery
should any governmental agency or entity, such as the EEOC or the DOL, pursue any claims on your behalf. You acknowledge that you are
knowingly and voluntarily waiving and releasing any rights you may have under the ADEA, as amended. You also acknowledge that (i) the
consideration given to you in exchange for the waiver and release in this Agreement is in addition to anything of value to which you were
already entitled; and (ii) that you have been paid for all time worked, have received all the leave, leaves of absence, leave benefits
and protections for which you are eligible, and have not suffered any on-the-job injury for which you have not already filed a claim.
You further acknowledge that you have been advised by this writing that: (a) your waiver and release do not apply to any rights or claims
that may arise after the execution date of this Agreement; (b) you have been advised hereby that you have the right to consult with an
attorney prior to executing this Agreement; (c) you have twenty-one (21) days to consider this Agreement (though you may choose to voluntarily
execute this Agreement earlier); (d) you have seven (7) days following your execution of this Agreement to revoke the Agreement; and (e)
this Agreement shall not be effective until the date upon which the revocation period has expired unexercised, which shall be the eighth
day after this Agreement is executed by you provided the Company has also executed the Release on or before that date (the “Release
Date”).

 

4.       Return
of Company Property. Within ten (10) days of the effective date of the termination of employment, you agree to return to the Company
all Company documents (and all copies thereof) and other Company property then in existence that you have had in your possession at
any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial
information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit
cards, entry cards, identification badges and keys; and, any materials of any kind that contain or embody any proprietary or
confidential information of the Company (and all reproductions thereof); provided, however, that you may retain copies of any
agreements by and between you and the Company, including, without limitation, your employment agreement, employee proprietary
information agreement, inventions, non-competition and non-solicitation agreement, side letter, promissory note, pledge agreement,
stock award agreement and other documents related to your equity to which you are a party. Receipt of the Severance described in
paragraph 2 of this Release is expressly conditioned upon return of all such Company property.

 

    12

     

    

 

5.       Confidentiality.
The provisions of this Release will be held in strictest confidence by you and the Company will not be publicized or disclosed in any
manner whatsoever; provided, however, that: (a) you may disclose this Agreement in confidence to your immediate family; (b) the parties
may disclose this Agreement in confidence to their attorney, accountant, auditor, tax preparer, and financial advisor; and (c) the parties
may disclose this Release insofar as such disclosure may be required by law.

 

6.       Proprietary
Information and Post-Termination Obligations. You acknowledge your surviving and continuing obligations under the Employment Agreement
not to use or disclose any confidential or proprietary information of the Company and its affiliates (as such term is defined in the Securities
Act of 1933, as amended) and to refrain from certain solicitation and competitive activities.

 

7.       Non-Disparagement.
You agree not to disparage the Company or its officers, directors, employees, shareholders, and agents in each case in any manner likely
to be harmful to them or their business, business reputation or personal reputation provided that you will respond accurately and fully
to any question, inquiry or request for information when required by legal process.

 

8.        Permissibility
of Disclosure. 18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any Federal
or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or
local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating
a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is
made under seal.” Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures
of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to
disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting
or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit
or other proceeding, but only if the filing is made under seal and protected from public disclosure.

 

9.       No
Admission. This Agreement does not constitute an admission by you or the Company of any wrongful action or violation of any federal, state,
or local statute or common law rights, including those relating to the provisions of any law or statute concerning employment actions
or of any other possible or claimed violation of law or rights.

 

10.       Breach.
You agree that upon any material breach by you of this Release as determined by an arbitrator or court of competent jurisdiction,
you will forfeit all amounts paid or owing to you under this Release. The parties acknowledge that it may be impossible to assess
the damages caused by the other party’s material violation of the terms of paragraphs 4, 5, 6, and 7 of this Release and
further agree that any threatened or actual material violation or breach of those paragraphs of this Release will constitute
immediate and irreparable injury to the non-breaching party. The parties therefore agree that any such breach of those paragraphs of
this Release is a material breach of this Agreement, and in addition to any and all other damages and remedies available, the
non-breaching party shall be entitled to seek an injunction to prevent the other party from violating or breaching this
Agreement.

 

    13

     

    

 

11.       Miscellaneous.
This Release constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard
to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly
contained herein and it supersedes any other such promises, warranties, or representations. This Release may not be modified or amended
except in a writing signed by both you and a duly authorized officer of the Company. This Release will bind the heirs, personal representatives,
successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and
assigns. If any provision of this Release is determined to be invalid or unenforceable, in whole or in part, this determination will not
affect any other provision of this Release, and the provision in question will be modified by the court so as to be rendered enforceable.
This Release will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of Maryland
as applied to contracts made and performed entirely within State of Maryland.

 

COMPANY

 

Nava Health MD, LLC

 

	By:	 	 	 
	 	[NAME AND TITLE]	 	Date

 

EXECUTIVE

 

	 	 	 
	[__________________]	 	Date

 

    14

     

    

 

EXHIBIT B

 

Prior Inventions

 

None

 

    15

     

    

 

EXHIBIT C

 

Restrictive Covenants

 

    16Exhibit 10.9

 

INDEMNIFICATION AGREEMENT

 

THIS INDEMNIFICATION AGREEMENT (“Agreement”)
is made and entered into as of the _____ day of _________, 2022, by and between Nava Health MD, Inc., a Maryland corporation (the
 “Company”), and ________________________ (“Indemnitee”).

 

WHEREAS, at the request of the Company, Indemnitee
currently serves as [a director] [and] [an officer] of the Company and may, therefore, be subjected to claims, suits or proceedings arising
as a result of such service;

 

WHEREAS, as an inducement to Indemnitee to serve
or continue to serve in such capacity, the Company has agreed to indemnify Indemnitee and to advance expenses and costs incurred by Indemnitee
in connection with any such claims, suits or proceedings, to the maximum extent permitted by law; and

 

WHEREAS, the parties by this Agreement desire to
set forth their agreement regarding indemnification and advance of expenses;

 

NOW, THEREFORE, in consideration of the premises
and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

 

Section 1.            Definitions.
For purposes of this Agreement:

 

(a)            “Change
in Control” means a change in control of the Company occurring after the Effective Date of a nature that would be required to be
reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or
form) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), whether or not the Company
is then subject to such reporting requirement; provided, however, that, without limitation, such a Change in Control shall be deemed to
have occurred if, after the Effective Date (i) any “person” (as such term is used in Sections 13(d) and 14(d) of
the Exchange Act) is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of securities of the Company representing 15% or more of the combined voting power of all of the Company’s then-outstanding
securities entitled to vote generally in the election of directors without the prior approval of at least two-thirds of the members of
the Board of Directors in office immediately prior to such person’s attaining such percentage interest; (ii) the Company is
a party to a merger, consolidation, sale of assets, plan of liquidation or other reorganization not approved by at least two-thirds of
the members of the Board of Directors then in office, as a consequence of which members of the Board of Directors in office immediately
prior to such transaction or event constitute less than a majority of the Board of Directors thereafter; or (iii) at any time, a
majority of the members of the Board of Directors are not individuals (A) who were directors as of the Effective Date or (B) whose
election by the Board of Directors or nomination for election by the Company’s stockholders was approved by the affirmative vote
of at least two-thirds of the directors then in office who were directors as of the Effective Date or whose election or nomination for
election was previously so approved.

 

     

     

    

 

(b)            “Corporate
Status” means the status of a person as a present or former director, officer, employee or agent of the Company or as a director,
trustee, officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, real
estate investment trust, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise that
such person is or was serving in such capacity at the request of the Company. As a clarification and without limiting the circumstances
in which Indemnitee may be serving at the request of the Company, service by Indemnitee shall be deemed to be at the request of the Company:
(i) if Indemnitee serves or served as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or agent
of any corporation, partnership, limited liability company, joint venture, trust or other enterprise (1) of which a majority of
the voting power or equity interest is or was owned directly or indirectly by the Company or (2) the management of which is controlled
directly or indirectly by the Company and (ii) if, as a result of Indemnitee’s service to the Company or any of its affiliated
entities, Indemnitee is subject to duties to, or required to perform services for, an employee benefit plan or its participants
or beneficiaries, including as a deemed fiduciary thereof.

 

(c)            “Disinterested
Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification and/or
advance of Expenses is sought by Indemnitee.

 

(d)            “Effective
Date” means the date set forth in the first paragraph of this Agreement.

 

(e)            “Expenses”
means any and all reasonable and out-of-pocket attorneys’ fees and costs, retainers, court costs, arbitration and mediation costs,
transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage,
delivery service fees, federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any
payments under this Agreement, ERISA excise taxes and penalties and any other disbursements or expenses incurred in connection with prosecuting,
defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in or otherwise participating in a Proceeding.
Expenses shall also include Expenses incurred in connection with any appeal resulting from any Proceeding, including, without limitation,
the premium for, security for and other costs relating to any cost bond, supersedeas bond or other appeal bond or its equivalent.

 

(f)            “Independent
Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither is, nor in the
past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other
than with respect to matters concerning Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements),
or (ii) any other party to or participant or witness in the Proceeding giving rise to a claim for indemnification or advance of Expenses
hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee
in an action to determine Indemnitee’s rights under this Agreement.

 

(g)            “Proceeding”
means any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry,
administrative hearing, claim, demand or discovery request or any other actual, threatened or completed proceeding, whether brought by
or in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal, administrative
or investigative (formal or informal) nature, including any appeal therefrom, except one pending or completed on or before the Effective
Date, unless otherwise specifically agreed in writing by the Company and Indemnitee. If Indemnitee reasonably believes that a given situation
may lead to or culminate in the institution of a Proceeding, such situation shall also be considered a Proceeding.

 

    -2- 

     

    

 

Section 2.            Services
by Indemnitee. Indemnitee serves or will serve in the capacity or capacities set forth in the first WHEREAS clause above. However,
this Agreement shall not impose any independent obligation on Indemnitee or the Company to continue Indemnitee’s service to the
Company. This Agreement shall not be deemed an employment contract between the Company (or any other entity) and Indemnitee.

 

Section 3.            General.
The Company shall indemnify, and advance Expenses to, Indemnitee (a) as provided in this Agreement and (b) otherwise to
the maximum extent permitted by Maryland law in effect on the Effective Date and as amended from time to time; provided, however, that
no change in Maryland law shall have the effect of reducing the benefits available to Indemnitee hereunder based on Maryland law as in
effect on the Effective Date. The rights of Indemnitee provided in this Section 3 shall include, without limitation, the rights set
forth in the other sections of this Agreement, including any additional indemnification permitted by the Maryland General Corporation
Law (the “MGCL”), including, without limitation, Section 2-418 of the MGCL.

 

Section 4.            Standard
for Indemnification. If, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be, made a party
to any Proceeding, the Company shall indemnify Indemnitee against all judgments, penalties, fines and amounts paid in settlement and all
Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with any such Proceeding unless
it is established that (a) the act or omission of Indemnitee was material to the matter giving rise to the Proceeding and (i) was
committed in bad faith or (ii) was the result of active and deliberate dishonesty, (b) Indemnitee actually received an improper
personal benefit in money, property or services or (c) in the case of any criminal Proceeding, Indemnitee had reasonable cause
to believe that Indemnitee’s conduct was unlawful.

 

Section 5.            Certain
Limits on Indemnification. Notwithstanding any other provision of this Agreement (other than Section 6), Indemnitee shall
not be entitled to:

 

(a)            indemnification
hereunder if the Proceeding was one by or in the right of the Company and Indemnitee is adjudged, in a final adjudication of the Proceeding
not subject to further appeal, to be liable to the Company;

 

(b)            indemnification
hereunder if Indemnitee is adjudged, in a final adjudication of the Proceeding not subject to further appeal, to be liable on the basis
that personal benefit in money, property or services was improperly received in any Proceeding charging improper personal benefit to Indemnitee,
whether or not involving action in Indemnitee’s Corporate Status; or

 

    -3- 

     

    

 

(c)            indemnification
or advance of Expenses hereunder if the Proceeding was brought by Indemnitee, unless: (i) the Proceeding was brought to enforce
indemnification under this Agreement, and then only to the extent in accordance with and as authorized by Section 12 of this Agreement,
or (ii) the Company’s charter or Bylaws, a resolution of the stockholders entitled to vote generally in the election of directors
or of the Board of Directors or an agreement approved by the Board of Directors to which the Company is a party expressly provide otherwise.

 

Section 6.            Court-Ordered
Indemnification. Notwithstanding any other provision of this Agreement, a court of appropriate jurisdiction, upon application of Indemnitee
and such notice as the court shall require, may order indemnification of Indemnitee by the Company in the following circumstances:

 

(a)            if
such court determines that Indemnitee is entitled to reimbursement under Section 2-418(d)(1) of the MGCL, the court shall order
indemnification, in which case Indemnitee shall be entitled to recover the Expenses of securing such reimbursement; or

 

(b)            if
such court determines that Indemnitee is fairly and reasonably entitled to indemnification in view of all the relevant circumstances,
whether or not Indemnitee (i) has met the standards of conduct set forth in Section 2-418(b) of the MGCL or (ii) has
been adjudged liable for receipt of an improper personal benefit under Section 2-418(c) of the MGCL, the court may order such
indemnification as the court shall deem proper without regard to any limitation on such court-ordered indemnification contemplated by
Section 2-418(d)(2)(ii) of the MGCL.

 

Section 7.            Indemnification
for Expenses of an Indemnitee Who is Wholly or Partially Successful. Notwithstanding any other provision of this Agreement, and without
limiting any such provision, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, made a party to
(or otherwise becomes a participant in) any Proceeding and is successful, on the merits or otherwise, in the defense of such Proceeding,
the Company shall indemnify Indemnitee for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf
in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to
one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee under this Section 7
for all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with each such claim, issue
or matter, allocated on a reasonable and proportionate basis. For purposes of this Section 7 and without limitation, the termination
of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result
as to such claim, issue or matter.

 

Section 8.            Advance
of Expenses for Indemnitee. If, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be, made
a party to any Proceeding, the Company shall, without requiring a preliminary determination of Indemnitee’s ultimate entitlement
to indemnification hereunder, advance all Expenses incurred by or on behalf of Indemnitee in connection with such Proceeding. The Company
shall make such advance of incurred Expenses within ten days after the receipt by the Company of a statement or statements requesting
such advance from time to time, whether prior to or after final disposition of such Proceeding, which advance may be in the form of,
in the reasonable discretion of Indemnitee (but without duplication), (a) payment of such Expenses directly to third parties on
behalf of Indemnitee, (b) advance of funds to Indemnitee in an amount sufficient to pay such Expenses or (c) reimbursement
to Indemnitee for Indemnitee’s payment of such Expenses. Such statement or statements shall reasonably evidence the Expenses incurred
by Indemnitee and shall include or be preceded or accompanied by a written affirmation by Indemnitee and a written undertaking by or
on behalf of Indemnitee, in substantially the form attached hereto as Exhibit A or in such form as may be required under
applicable law as in effect at the time of the execution thereof. To the extent that Expenses advanced to Indemnitee do not relate to
a specific claim, issue or matter in the Proceeding, such Expenses shall be allocated on a reasonable and proportionate basis. The undertaking
required by this Section 8 shall be an unlimited general obligation by or on behalf of Indemnitee and shall be accepted without
reference to Indemnitee’s financial ability to repay such advanced Expenses and without any requirement to post security therefor.

 

    -4- 

     

    

 

Section 9.            Indemnification
and Advance of Expenses as a Witness or Other Participant. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is or may be, by reason of Indemnitee’s Corporate Status, made a witness or otherwise asked to participate in any Proceeding,
whether instituted by the Company or any other person, and to which Indemnitee is not a party, Indemnitee shall be advanced and indemnified
against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith within ten
days after the receipt by the Company of a statement or statements requesting any such advance or indemnification from time to time, whether
prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by
Indemnitee. In connection with any such advance of Expenses, the Company may require Indemnitee to provide an undertaking and affirmation
substantially in the form attached hereto as Exhibit A or in such form as may be required under applicable law as in effect
at the time of execution thereof.

 

Section 10.          Procedure
for Determination of Entitlement to Indemnification.

 

(a)            To
obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith
such documentation and information as is reasonably available to Indemnitee and is reasonably necessary or appropriate to determine whether
and to what extent Indemnitee is entitled to indemnification. Indemnitee may submit one or more such requests from time to time and at
such time(s) as Indemnitee deems appropriate in Indemnitee’s sole discretion. The officer of the Company receiving any such
request from Indemnitee shall, promptly upon receipt of such a request for indemnification, advise the Board of Directors in writing that
Indemnitee has requested indemnification.

 

(b)            Upon
written request by Indemnitee for indemnification pursuant to Section 10(a) above, a determination, if required by applicable
law, with respect to Indemnitee’s entitlement thereto shall promptly be made in the specific case: (i) if a Change in Control
has occurred, by Independent Counsel, in a written opinion to the Board of Directors, a copy of which shall be delivered to Indemnitee,
which Independent Counsel shall be selected by Indemnitee and approved by the Board of Directors in accordance with Section 2-418(e)(2)(ii) of
the MGCL, which approval shall not be unreasonably withheld; or (ii) if a Change in Control has not occurred, (A) by a majority
vote of the Disinterested Directors or by the majority vote of a group of Disinterested Directors designated by the Disinterested Directors
to make the determination, (B) if Independent Counsel has been selected by the Board of Directors in accordance with Section 2-418(e)(2)(ii) of
the MGCL and approved by Indemnitee, which approval shall not be unreasonably withheld or delayed, by Independent Counsel, in a written
opinion to the Board of Directors, a copy of which shall be delivered to Indemnitee or (C) if so directed by the Board of Directors,
by the stockholders of the Company, other than directors or officers who are parties to the Proceeding. If it is so determined that Indemnitee
is entitled to indemnification, the Company shall make payment to Indemnitee within ten days after such determination. Indemnitee shall
cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification,
including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary or appropriate to such
determination in the discretion of the Board of Directors or Independent Counsel if retained pursuant to clause (ii)(B) of this
Section 10(b). Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such determination
shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company
shall indemnify and hold Indemnitee harmless therefrom.

 

    -5- 

     

    

 

(c)            The
Company shall pay the reasonable fees and expenses of Independent Counsel, if one is appointed.

 

Section 11.          Presumptions
and Effect of Certain Proceedings.

 

(a)            In
making any determination with respect to entitlement to indemnification hereunder, the person or persons (including any court having jurisdiction
over the matter) making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee
has submitted a request for indemnification in accordance with Section 10(a) of this Agreement, and the Company shall have the
burden of overcoming that presumption in connection with the making of any determination contrary to that presumption.

 

(b)            The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, upon a plea of nolo
contendere or its equivalent, or entry of an order of probation prior to judgment, does not create a presumption that Indemnitee did
not meet the requisite standard of conduct described herein for indemnification.

 

(c)            The
knowledge and/or actions, or failure to act, of any other director, officer, employee or agent of the Company or any other director, trustee,
officer, partner, manager, managing member, fiduciary, employee or agent of any other foreign or domestic corporation, real estate investment
trust, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise shall not be imputed to
Indemnitee for purposes of determining any other right to indemnification under this Agreement.

 

Section 12.          Remedies
of Indemnitee.

 

(a)            If
(i) a determination is made pursuant to Section 10(b) of this Agreement that Indemnitee is not entitled to indemnification
under this Agreement, (ii) advance of Expenses is not timely made pursuant to Sections 8 or 9 of this Agreement, (iii) no determination
of entitlement to indemnification shall have been made pursuant to Section 10(b) of this Agreement within 60 days after receipt
by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 7 or 9 of this
Agreement within ten days after receipt by the Company of a written request therefor, or (v) payment of indemnification pursuant
to any other section of this Agreement or the charter or Bylaws of the Company is not made within ten days after a determination has
been made that Indemnitee is entitled to indemnification, Indemnitee shall be entitled to an adjudication in an appropriate court
located in the State of Maryland, or in any other court of competent jurisdiction, or in an arbitration conducted by a single arbitrator
pursuant to the Commercial Arbitration Rules of the American Arbitration Association, of Indemnitee’s entitlement to indemnification
or advance of Expenses. Indemnitee shall commence a proceeding seeking an adjudication or an award in arbitration within 180 days following
the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 12(a); provided, however,
that the foregoing clause shall not apply to a proceeding brought by Indemnitee to enforce Indemnitee’s rights under Section 7
of this Agreement. Except as set forth herein, the provisions of Maryland law (without regard to its conflicts of laws rules) shall apply
to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

 

    -6- 

     

    

 

(b)            In
any judicial proceeding or arbitration commenced pursuant to this Section 12, Indemnitee shall be presumed to be entitled to
indemnification or advance of Expenses, as the case may be, under this Agreement and the Company shall have the burden of proving that
Indemnitee is not entitled to indemnification or advance of Expenses, as the case may be. If Indemnitee commences a judicial proceeding
or arbitration pursuant to this Section 12, Indemnitee shall not be required to reimburse the Company for any advances pursuant
to Section 8 of this Agreement until a final determination is made with respect to Indemnitee’s entitlement to indemnification
(as to which all rights of appeal have been exhausted or lapsed). The Company shall, to the fullest extent not prohibited by law, be precluded
from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 12 that the procedures and presumptions
of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the
Company is bound by all of the provisions of this Agreement.

 

(c)            If
a determination shall have been made pursuant to Section 10(b) of this Agreement that Indemnitee is entitled to indemnification,
the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 12,
absent a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement
not materially misleading, in connection with the request for indemnification that was not disclosed in connection with the determination.

 

(d)            In
the event that Indemnitee is successful in seeking, pursuant to this Section 12, a judicial adjudication of or an award in arbitration
to enforce Indemnitee’s rights under, or to recover damages for breach of, this Agreement, Indemnitee shall be entitled to
recover from the Company, and shall be indemnified by the Company for, any and all Expenses actually and reasonably incurred by Indemnitee
in such judicial adjudication or arbitration. If it shall be determined in such judicial adjudication or arbitration that Indemnitee
is entitled to receive part but not all of the indemnification or advance of Expenses sought, the Expenses incurred by Indemnitee in
connection with such judicial adjudication or arbitration shall be appropriately prorated.

 

    -7- 

     

    

 

(e)            Interest
shall be paid by the Company to Indemnitee at the maximum rate allowed to be charged for judgments under the Courts and Judicial Proceedings
Article of the Annotated Code of Maryland for amounts which the Company pays or is obligated to pay for the period (i) commencing
with either the tenth day after the date on which the Company was requested to advance Expenses in accordance with Sections 8 or 9 of
this Agreement or the 60th day after the date on which the Company was requested to make the determination of entitlement to
indemnification under Section 10(b) of this Agreement, as applicable, and (ii) ending on the date such payment is made
to Indemnitee by the Company.

 

Section 13.          Defense
of the Underlying Proceeding.

 

(a)            Indemnitee
shall notify the Company promptly in writing upon being served with any summons, citation, subpoena, complaint, indictment, request or
other document relating to any Proceeding which may result in the right to indemnification or the advance of Expenses hereunder and shall
include with such notice a description of the nature of the Proceeding and a summary of the facts underlying the Proceeding. The failure
to give any such notice shall not disqualify Indemnitee from the right, or otherwise affect in any manner any right of Indemnitee, to
indemnification or the advance of Expenses under this Agreement unless the Company’s ability to defend in such Proceeding or to
obtain proceeds under any insurance policy is materially and adversely prejudiced thereby, and then only to the extent the Company is
thereby actually so prejudiced.

 

(b)            Subject
to the provisions of the last sentence of this Section 13(b) and of Section 13(c) below, the Company shall have the
right to defend Indemnitee in any Proceeding which may give rise to indemnification hereunder; provided, however, that the Company shall
notify Indemnitee of any such decision to defend within 15 days following receipt of notice of any such Proceeding under Section 13(a) above.
The Company shall not, without the prior written consent of Indemnitee, which shall not be unreasonably withheld or delayed, consent to
the entry of any judgment against Indemnitee or enter into any settlement or compromise with respect to Indemnitee which (i) includes
an admission of fault of Indemnitee, (ii) does not include, as an unconditional term thereof, the full release of Indemnitee from
all liability in respect of such Proceeding, which release shall be in form and substance reasonably satisfactory to Indemnitee, or (iii) would
impose any Expense, judgment, fine, penalty or limitation on Indemnitee. This Section 13(b) shall not apply to a Proceeding
brought by Indemnitee under Section 12 of this Agreement.

 

(c)            Notwithstanding
the provisions of Section 13(b) above, if in a Proceeding to which Indemnitee is a party by reason of Indemnitee’s Corporate
Status, (i) Indemnitee reasonably concludes, based upon an opinion of counsel approved by the Company, which approval shall not
be unreasonably withheld or delayed, that Indemnitee may have separate defenses or counterclaims to assert with respect to any issue
which may not be consistent with other defendants in such Proceeding, (ii) Indemnitee reasonably concludes, based upon an opinion
of counsel approved by the Company, which approval shall not be unreasonably withheld or delayed, that an actual or apparent conflict
of interest or potential conflict of interest exists between Indemnitee and the Company, or (iii) if the Company fails to assume
the defense of such Proceeding in a timely manner, Indemnitee shall be entitled to be represented by separate legal counsel of Indemnitee’s
choice, subject to the prior approval of the Company, which approval shall not be unreasonably withheld or delayed, at the expense of
the Company. In addition, if the Company fails to comply with any of its obligations under this Agreement or in the event that the Company
or any other person takes any action to declare this Agreement void or unenforceable, or institutes any Proceeding to deny or to recover
from Indemnitee the benefits intended to be provided to Indemnitee hereunder, Indemnitee shall have the right to retain counsel
of Indemnitee’s choice, subject to the prior approval of the Company, which approval shall not be unreasonably withheld or delayed,
at the expense of the Company (subject to Section 12(d) of this Agreement), to represent Indemnitee in connection with any
such matter.

 

    -8- 

     

    

 

Section 14.          Non-Exclusivity;
Survival of Rights; Subrogation.

 

(a)            The
rights of indemnification and advance of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which
Indemnitee may at any time be entitled under applicable law, the charter or Bylaws of the Company, any agreement or a resolution of the
stockholders entitled to vote generally in the election of directors or of the Board of Directors, or otherwise. Unless consented to in
writing by Indemnitee, no amendment, alteration or repeal of the charter or Bylaws of the Company, this Agreement or of any provision
hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee
in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal, regardless of whether a claim with respect to such
action or inaction is raised prior or subsequent to such amendment, alteration or repeal. No right or remedy herein conferred is intended
to be exclusive of any other right or remedy, and every other right or remedy shall be cumulative and in addition to every other right
or remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion of any right or remedy hereunder,
or otherwise, shall not prohibit the concurrent assertion or employment of any other right or remedy.

 

(b)            In
the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery
of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Company to bring suit to enforce such rights.

 

Section 15.          Insurance.

 

(a)            The
Company will use its reasonable best efforts to acquire directors and officers liability insurance, on terms and conditions deemed appropriate
by the Board of Directors, with the advice of counsel, covering Indemnitee or any claim made against Indemnitee by reason of Indemnitee’s
Corporate Status and covering the Company for any indemnification or advance of Expenses made by the Company to Indemnitee for any claims
made against Indemnitee by reason of Indemnitee’s Corporate Status. In the event of a Change in Control, the Company shall maintain
in force any and all directors and officers liability insurance policies that were maintained by the Company immediately prior to the
Change in Control for a period of six years with the insurance carrier or carriers and through the insurance broker in place at the time
of the Change in Control; provided, however, (i) if the carriers will not offer the same policy and an expiring policy needs to
be replaced, a policy substantially comparable in scope and amount shall be obtained and (ii) if any replacement insurance carrier
is necessary to obtain a policy substantially comparable in scope and amount, such insurance carrier shall have an AM Best rating that
is the same or better than the AM Best rating of the existing insurance carrier; provided, further, however, in no event shall the Company
be required to expend in the aggregate in excess of 250% of the annual premium or premiums paid by the Company for directors and officers
liability insurance in effect on the date of the Change in Control. In the event that 250% of the annual premium paid by the Company
for such existing directors and officers liability insurance is insufficient for such coverage, the Company shall spend up to that amount
to purchase such lesser coverage as may be obtained with such amount.

 

    -9- 

     

    

 

(b)            Without
in any way limiting any other obligation under this Agreement, the Company shall indemnify Indemnitee for any payment by Indemnitee which
would otherwise be indemnifiable hereunder arising out of the amount of any deductible or retention and the amount of any excess of the
aggregate of all judgments, penalties, fines, settlements and Expenses incurred by Indemnitee in connection with a Proceeding over the
coverage of any insurance referred to in Section 15(a). The purchase, establishment and maintenance of any such insurance shall not
in any way limit or affect the rights or obligations of the Company or Indemnitee under this Agreement except as expressly provided herein,
and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights or obligations
of the Company under any such insurance policies. If, at the time the Company receives notice from any source of a Proceeding to which
Indemnitee is a party or a participant (as a witness or otherwise) the Company has director and officer liability insurance in effect,
the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective
policies.

 

(c)            The
Indemnitee shall cooperate with the Company or any insurance carrier of the Company with respect to any Proceeding.

 

Section 16.          Coordination
of Payments. The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable or payable
or reimbursable as Expenses hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance
policy, contract, agreement or otherwise.

 

Section 17.          Contribution.
If the indemnification provided in this Agreement is unavailable in whole or in part and may not be paid to Indemnitee for any reason,
other than for failure to satisfy the standard of conduct set forth in Section 4 or due to the provisions of Section 5, then,
with respect to any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding), to the
fullest extent permissible under applicable law, the Company, in lieu of indemnifying and holding harmless Indemnitee, shall pay, in the
first instance, the entire amount incurred by Indemnitee, whether for Expenses, judgments, penalties, and/or amounts paid or to be paid
in settlement, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives
and relinquishes any right of contribution it may have at any time against Indemnitee.

 

    -10- 

     

    

 

Section 18.          Reports
to Stockholders. To the extent required by the MGCL, the Company shall report in writing to its stockholders the payment of any amounts
for indemnification of, or advance of Expenses to, Indemnitee under this Agreement arising out of a Proceeding by or in the right
of the Company with the notice of the meeting of stockholders of the Company next following the date of the payment of any such indemnification
or advance of Expenses or prior to such meeting.

 

Section 19.          Duration
of Agreement; Binding Effect.

 

(a)            This
Agreement shall continue until and terminate on the later of (i) the date that Indemnitee shall have ceased to serve as a director,
officer, employee or agent of the Company or as a director, trustee, officer, partner, manager, managing member, fiduciary, employee or
agent of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company, joint venture,
trust, employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of the Company and
(ii) the date that Indemnitee is no longer subject to any actual or possible Proceeding (including any rights of appeal thereto and
any Proceeding commenced by Indemnitee pursuant to Section 12 of this Agreement).

 

(b)           The
indemnification and advance of Expenses provided by, or granted pursuant to, this Agreement shall be binding upon and be enforceable by
the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation
or otherwise to all or substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased
to be a director, officer, employee or agent of the Company or a director, trustee, officer, partner, manager, managing member, fiduciary,
employee or agent of any other foreign or domestic corporation, real estate investment trust, partnership, limited liability company,
joint venture, trust, employee benefit plan or other enterprise that such person is or was serving in such capacity at the request of
the Company, and shall inure to the benefit of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisees, executors and administrators
and other legal representatives.

 

(c)            The
Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to
perform if no such succession had taken place.

 

(d)            The
Company and Indemnitee agree that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable
and difficult to ascertain, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto
agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity
of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall
not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled. Indemnitee shall further be entitled
to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions,
without the necessity of posting bonds or other undertakings in connection therewith. The Company acknowledges that, in the absence of
a waiver, a bond or undertaking may be required of Indemnitee by a court, and the Company hereby waives any such requirement of such
a bond or undertaking.

 

    -11- 

     

    

 

Section 20.          Severability.
If any provision or provisions of this Agreement shall be held to be invalid, void, illegal or otherwise unenforceable for any reason
whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation,
each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, void, illegal or
otherwise unenforceable that is not itself invalid, void, illegal or otherwise unenforceable) shall not in any way be affected or impaired
thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed
to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to
the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or
sentence of this Agreement containing any such provision held to be invalid, void, illegal or otherwise unenforceable, that is not itself
invalid, void, illegal or otherwise unenforceable) shall be construed so as to give effect to the intent manifested thereby.

 

Section 21.          Counterparts.
This Agreement may be executed in one or more counterparts, (delivery of which may be by facsimile, or via e-mail as a portable document
format (.pdf) or other electronic format), each of which will be deemed to be an original, and it will not be necessary in making proof
of this Agreement or the terms of this Agreement to produce or account for more than one such counterpart. One such counterpart signed
by the party against whom enforceability is sought shall be sufficient to evidence the existence of this Agreement.

 

Section 22.          Headings.
The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this
Agreement or to affect the construction thereof.

 

Section 23.          Modification
and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the
parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions
hereof (whether or not similar) nor, unless otherwise expressly stated, shall such waiver constitute a continuing waiver.

 

Section 24.          Notices.
All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given if (i) delivered
by hand and receipted for by the party to whom said notice or other communication shall have been directed, on the day of such delivery,
or (ii) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed:

 

(a)            If
to Indemnitee, to the address set forth on the signature page hereto.

 

    -12- 

     

    

 

(b)            If
to the Company, to:

 

Nava Health MD, Inc.

9755 Patuxent Woods Drive, Ste. 100

Columbia, Maryland 21046

 

or to such other address as may have been furnished in writing to Indemnitee
by the Company or to the Company by Indemnitee, as the case may be.

 

Section 25.          Governing
Law. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Maryland, without
regard to its conflicts of laws rules.

 

[SIGNATURE PAGE FOLLOWS]

 

    -13- 

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the day and year first above written.

 

	 	COMPANY:
	 	 
	 	NAVA HEALTH MD, INC.

 

 

		By:	 
	 	 	Name:
	 	 	Title:

 

 

	 	INDEMNITEE:
	 	 
	 	
	 	Name:
	 	Address:

 

    -14- 

     

    

 

EXHIBIT A

 

AFFIRMATION AND UNDERTAKING TO REPAY EXPENSES ADVANCED

 

To: The Board of Directors of Nava Health MD, Inc.

 

Re: Affirmation and Undertaking

 

Ladies and Gentlemen:

 

This Affirmation and Undertaking is being provided
pursuant to that certain Indemnification Agreement dated the _____ day of ______________, 20__, by and between Nava Health MD, Inc.,
a Maryland corporation (the “Company”), and the undersigned Indemnitee (the “Indemnification Agreement”), pursuant
to which I am entitled to advance of Expenses in connection with [Description of Proceeding] (the “Proceeding”).

 

Terms used herein and not otherwise defined shall
have the meanings specified in the Indemnification Agreement.

 

I am subject to the Proceeding by reason of my
Corporate Status or by reason of alleged actions or omissions by me in such capacity. I hereby affirm my good faith belief that at all
times, insofar as I was involved as [a director] [and] [an officer] of the Company, in any of the facts or events giving rise to the Proceeding, I
(1) did not act with bad faith or active or deliberate dishonesty, (2) did not receive any improper personal benefit in money,
property or services and (3) in the case of any criminal proceeding, had no reasonable cause to believe that any act or omission
by me was unlawful.

 

In consideration of the advance by the Company
for Expenses incurred by me in connection with the Proceeding (the “Advanced Expenses”), I hereby agree that if, in connection
with the Proceeding, it is established that (1) an act or omission by me was material to the matter giving rise to the Proceeding
and (a) was committed in bad faith or (b) was the result of active and deliberate dishonesty or (2) I actually received
an improper personal benefit in money, property or services or (3) in the case of any criminal proceeding, I had reasonable
cause to believe that the act or omission was unlawful, then I shall promptly reimburse the portion of the Advanced Expenses relating
to the claims, issues or matters in the Proceeding as to which the foregoing findings have been established.

 

IN WITNESS WHEREOF, I have executed this Affirmation
and Undertaking on this ___ day of ____________________, 20____.

 

		Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]